Zimmer Holdings Earnings Preview: Analysts Expect Higher EPS, Revenue
Zimmer Holdings (NYSE: ZMH) releases its next round of earnings this Thursday, October 27, 2011. Here's Benzinga's advanced look at Zimmer Holdings' third quarter earnings report.
Earnings and Revenue:
Wall Street expects an EPS of $1.03/share and revenues of $1.03 billion. Zimmer Holdings' latest numbers will no doubt be compared with the company's year-ago quarter, when it reported a profit of 96 cents/share on revenues of $965 million. We'll know on Thursday whether Zimmer Holdings has managed the estimated 7.3% increase in EPS and 6.7% rise in revenues on a year-over-year basis.
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q2 | Q1 | Q4 | Q3 |
| EPS Estimate | $1.19 | $1.13 | $1.19 | $0.95 |
| EPS Actual | $1.21 | $1.19 | $1.27 | $0.96 |
Stock Performance:
As of October 24, 2011, Zimmer Holdings' current share price was $55. Since January 1st, shares of Zimmer Holdings have given investors a return of 2.5%. For a full 12 months, the return has risen by 6%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
- Long-term shareholders are already enjoying 12-month gains prior to the announcement
Average Stock Rating:
The average rating by analysts for Zimmer Holdings is a Hold. This rating has strengthened slightly over the past ninety days.
Competitors:
Wondering how some of the other healthcare companies are doing? Here are a few of Zimmer Holdings' peers in that sector.
- Alphatec Holdings (NASDAQ: ATEC): Moderate Buy with a -$0.02 recent quarter EPS
- Exactech (NASDAQ: EXAC): Moderate Buy with a $0.28 recent quarter EPS
- NuVasive (NASDAQ: NUVA): Moderate Buy with a $0.19 recent quarter EPS
- MAKO SURGICAL (MAKO): Hold with a -$0.24 recent quarter EPS
The medical products company's industry has seen price/earnings growth of 1.5% during the current fiscal year.
Finally, a description of the company's main areas of operation: Zimmer Holdings designs, develops, manufactures and markets orthopedic and dental reconstructive implants, spinal implants, and trauma products.
Take Action:
That's your advanced look at Zimmer Holdings' upcoming earnings numbers -- be ready to take quick action if the company's report contains any surprises. Also, check back in with us after the announcement for a full recap and what-to-do-next guide.
- To see up-to-date news on Zimmer Holdings, click here
- To see other trading ideas, click here
- To see other company earnings recaps, click here
